Initial respiratory status in hyperleukocytic acute myeloid leukemia: prognostic significance and effect of leukapheresis

被引:10
作者
Van de Louw, Andry [1 ]
Schneider, Coursen W. [2 ]
Desai, Ruchi J. [2 ]
Claxton, David F. [3 ]
机构
[1] Penn State Milton S Hershey Med Ctr & Coll Med, Div Pulm & Crit Care Med, Hershey, PA USA
[2] Penn State Milton S Hershey Med Ctr & Coll Med, Dept Internal Med, Hershey, PA USA
[3] Penn State Milton S Hershey Med Ctr & Coll Med, Div Hematol & Oncol, Hershey, PA USA
关键词
Acute myeloid leukemia; leukapheresis; leukostasis; acute respiratory failure; ACUTE MONOCYTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; EARLY MORTALITY; THERAPEUTIC LEUKAPHERESIS; CHEMOTHERAPY; IMPACT; LEUKOSTASIS; DIAGNOSIS; SURVIVAL;
D O I
10.3109/10428194.2015.1094695
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study investigated whether initial respiratory status in hyperleukocytic acute myeloid leukemia (AML), as defined by oxygen/ventilatory support, is (1) associated with early mortality and overall survival and (2) improved after leukapheresis. A retrospective chart review of 89 patients requiring leukapheresis was performed. White blood cell count (WBC) decreased from 153 (56-475)x10(9)/L to 60 (17-259)x10(9)/L after first leukapheresis (p<0.01). Initial respiratory status was room air (n=40), low (n=31) or high flow oxygen therapy (n=8) or mechanical ventilation (n=10). As compared to admission, respiratory status significantly deteriorated after both first and second leukapheresis (p<0.01) and was not different at day 5 for patients still alive (p=0.131). Both day 28 mortality and overall survival were significantly affected by initial respiratory status (p<0.01). Despite being effective in reducing WBC, leukapheresis did not improve respiratory status of hyperleukocytic AML patients, a factor strongly associated with survival.
引用
收藏
页码:1319 / 1326
页数:8
相关论文
共 30 条
[1]   Acute Pulmonary Failure During Remission Induction Chemotherapy in Adults With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [J].
Al Ameri, Ali ;
Koller, Charles ;
Kantarjian, Hagop ;
Ravandi, Farhad ;
Verstovsek, Srdan ;
Borthakur, Gautam ;
Pierce, Sherry ;
Mattiuzzi, Gloria .
CANCER, 2010, 116 (01) :93-97
[2]   Dexamethasone in patients with acute lung injury from acute monocytic leukaemia [J].
Azoulay, E. ;
Canet, E. ;
Raffoux, E. ;
Lengline, E. ;
Lemiale, V. ;
Vincent, F. ;
de Labarthe, A. ;
Seguin, A. ;
Boissel, N. ;
Dombret, H. ;
Schlemmer, B. .
EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (03) :648-653
[3]   Acute monocytic leukemia presenting as acute respiratory failure [J].
Azoulay, É ;
Fieux, F ;
Moreau, D ;
Thiery, G ;
Rousselot, P ;
Parrot, A ;
Le Gall, JR ;
Dombret, H ;
Schlemmer, B .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (10) :1329-1333
[4]   Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia [J].
Bertoli, Sarah ;
Berard, Emilie ;
Huguet, Francoise ;
Huynh, Anne ;
Tavitian, Suzanne ;
Vergez, Francois ;
Dobbelstein, Sophie ;
Dastugue, Nicole ;
Mansat-De Mas, Veronique ;
Delabesse, Eric ;
Duchayne, Eliane ;
Demur, Cecile ;
Sarry, Audrey ;
Lauwers-Cances, Valerie ;
Laurent, Guy ;
Attal, Michel ;
Recher, Christian .
BLOOD, 2013, 121 (14) :2618-2626
[5]   Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis [J].
Bug, Gesine ;
Anargyrou, Konstantinos ;
Tonn, Torsten ;
Bialleck, Heike ;
Seifried, Erhard ;
Hoelzer, Dieter ;
Ottmann, Oliver G. .
TRANSFUSION, 2007, 47 (10) :1843-1850
[6]   DIFFERING COMPLICATIONS OF HYPERLEUKOCYTOSIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC OR ACUTE NONLYMPHOBLASTIC LEUKEMIA [J].
BUNIN, NJ ;
PUI, CH .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) :1590-1595
[7]   Incidence and prognostic value of respiratory events in acute leukemia [J].
Chaoui, D ;
Legrand, O ;
Roche, N ;
Cornet, M ;
Lefebvre, A ;
de Latour, RP ;
Sanhes, L ;
Huchon, G ;
Marie, JP ;
Rabbat, A .
LEUKEMIA, 2004, 18 (04) :670-675
[8]   Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].
Cheson, BD ;
Bennett, JM ;
Kopecky, KJ ;
Büchner, T ;
Willman, CL ;
Estey, EH ;
Schiffer, CA ;
Döhner, H ;
Tallman, MS ;
Lister, TA ;
LoCocco, F ;
Willemze, R ;
Biondi, A ;
Hiddemann, W ;
Larson, RA ;
Löwenberg, B ;
Sanz, MA ;
Head, DR ;
Ohno, R ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649
[9]  
CREUTZIG U, 1987, CANCER-AM CANCER SOC, V60, P3071, DOI 10.1002/1097-0142(19871215)60:12<3071::AID-CNCR2820601235>3.0.CO
[10]  
2-Y